Oxygen therapy shows promise for fibromyalgia pain relief

NCT ID NCT03325959

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen therapy) could reduce pain and improve quality of life in people with fibromyalgia, compared to standard medications like Cymbalta or Lyrica. Seventy-six adults with fibromyalgia and a history of physical trauma took part. The goal was to see if this non-drug approach could offer a new way to manage symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
hyperbaric oxygen therapy
What this could lead to
If it works, this could provide a non-drug option to ease fibromyalgia pain and improve daily life.
What could go wrong
This is a small, completed trial with 76 participants. The results may not apply to everyone, and hyperbaric oxygen therapy is time-consuming and not widely available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Assaf-Harofeh Medical Center

    Ẕerifin, 70300, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.